规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
g | ¥ ƪȅȮƗƗ | 6 | > 1 | 1 | 2 | 1 | 1 | ¥ ƪȅȮƗƗ | - + |
1g | ¥ ǠƪȮƗƗ | 3 | > 1 | -- | -- | -- | -- | ¥ ǠƪȮƗƗ | - + |
2g | ¥ ƉƪǠȮƗƗ | 1 | > 1 | 1 | 1 | 1 | 3 | ¥ ƉƪǠȮƗƗ | - + |
1g | ¥ ſȹȹȮƗƗ | -- | 7 | 1 | -- | -- | -- | ¥ ſȹȹȮƗƗ | - + |
g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
1g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
78.67
[1]. Reddy GN, et al. Quality assurance and quality control methods for animal and human applications of no-carrier-added 6-[18F]fluorodopa for PET investigations of dopaminergic systems. Appl Radiat Isot. 1993;(7):993-998.
[2]. Zhang Lan, et al. Preparation of 6-[<sup>18</sup>F]fluoro-L-DOPA and its biodistribution in normal and unilateral PD model rats. Nuclear Science and Techniques, 13(), 2-2.
H32-H31-H319-H33
P261-P26-P27-P271-P28-P32+P32-P3+P3-P3+P31+P338-P33-P362+P36-P3+P233-P-P1
GHS7